Laura M. Woods

Laura M. Woods

Auto-generated profile, based on publicly available information

Laura M. Woods

University of Cambridge 1 Cambridge Stem Cell Institute, Jeffrey Cheah Biomedical Centre Cambridge, United Kingdom

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 September 2017 in Nature Communications
Verified
Journal Article
Open access
PDF file
LWLaura Woods
Laura Woods
VPVicente Pérez-García
Vicente Pérez-García
JKJens Kieckbusch
Jens Kieckbusch
XWXiaoqiu Wang
Xiaoqiu Wang
FDFrancesco DeMayo
Francesco DeMayo
MHMyriam Hemberger
Myriam Hemberger
Mammalian reproductive performance declines rapidly with advanced maternal age. This effect is largely attributed to the exponential increase in chromosome segregation errors in the oocyte with age. Yet many pregnancy complications and birth defects that become more frequent in older mothers, in both humans and mice, occur in the absence of karyotypic abnormalities. Here, we report that abnormal embryonic development in aged female mice is associated with severe placentation defects, which result from major deficits in the decidualisation response of the uterine stroma. This problem is rooted in a blunted hormonal responsiveness of the ageing uterus. Importantly, a young uterine environment can restore normal placental as well as embryonic development. Our data highlight the pivotal, albeit under-appreciated, impact of maternal age on uterine adaptability to pregnancy as major contributor to the decline in reproductive success in older females.

1 December 2020 in Molecular Cancer Research
Verified
Journal Article
Open access
PDF file
FAFahad R. Ali
Fahad R. Ali
DMDaniel Marcos
Daniel Marcos
ICIgor Chernukhin
Igor Chernukhin
LWLaura M. Woods
Laura M. Woods
LPLydia M. Parkinson
Lydia M. Parkinson
APAnna Philpott
Anna Philpott
Pediatric cancers often resemble trapped developmental intermediate states that fail to engage the normal differentiation program, typified by high-risk neuroblastoma arising from the developing sympathetic nervous system. Neuroblastoma cells resemble arrested neuroblasts trapped by a stable but aberrant epigenetic program controlled by sustained expression of a core transcriptional circuit of developmental regulators in conjunction with elevated MYCN or MYC (MYC). The transcription factor ASCL1 is a key master regulator in neuroblastoma and has oncogenic and tumor-suppressive activities in several other tumor types. Using functional mutational approaches, we find that preventing CDK-dependent phosphorylation of ASCL1 in neuroblastoma cells drives coordinated suppression of the MYC-driven core circuit supporting neuroblast identity and proliferation, while simultaneously activating an enduring gene program driving mitotic exit and neuronal differentiation. Implications: These findings indicate that targeting phosphorylation of ASCL1 may offer a new approach to development of differentiation therapies in neuroblastoma.

4 February 2024 in bioRxiv
Verified
Preprint
Open access
PDF file
CSClaire S. Simon
Claire S. Simon
AMAfshan McCarthy
Afshan McCarthy
LWLaura Woods
Laura Woods
DSDesislava Staneva
Desislava Staneva
QHQiulin Huang
Qiulin Huang
KNKathy K. Niakan
Kathy K. Niakan
Studies in the mouse demonstrate the importance of fibroblast growth factor (FGF) and extra-cellular receptor tyrosine kinase (ERK) in specification of embryo-fated epiblast and yolk-sac-fated hypoblast cells from uncommitted inner cell mass (ICM) cells prior to implantation. Molecular mechanisms regulating specification of early lineages in human development are comparatively unclear. Here we show that exogenous FGF stimulation leads to expanded hypoblast molecular marker expression, at the expense of the epiblast. Conversely, we show that specifically inhibiting ERK activity leads to expansion of epiblast cells functionally capable of giving rise to naïve human pluripotent stem cells. Single-cell transcriptomic analysis indicates that these epiblast cells downregulate FGF signalling and upregulate molecular markers associated with naïve pluripotency. Our functional study demonstrates for the first time the molecular mechanisms governing ICM specification in human development, whereby segregation of the epiblast and hypoblast lineages occurs during maturation of the mammalian embryo in an ERK signal-dependent manner.

4 August 2026
Verified
Other
Open access
LMLidiya Mykhaylechko
Lidiya Mykhaylechko
RGRoshna L. Gomez
Roshna L. Gomez
LWLaura M. Woods
Laura M. Woods
EPEvangelia K. Papachristou
Evangelia K. Papachristou
RRRevathy Ramachandran
Revathy Ramachandran
APAnna Philpott
Anna Philpott
Excel file of the ASCL1 interactors in dox treated BEASCL1 versus IMRASCL1 identified with ASCL1 qPLEX-RIME.

4 August 2026
Verified
Other
Open access
LMLidiya Mykhaylechko
Lidiya Mykhaylechko
RGRoshna L. Gomez
Roshna L. Gomez
LWLaura M. Woods
Laura M. Woods
EPEvangelia K. Papachristou
Evangelia K. Papachristou
RRRevathy Ramachandran
Revathy Ramachandran
APAnna Philpott
Anna Philpott
Figure S4. ASCL1 protein-protein interactome is enriched for regulators of neuronal differentiation in the IMR ASCL1 cell line and cell cycle components in the BE ASCL1 cell line.

4 August 2026
Verified
Other
Open access
LMLidiya Mykhaylechko
Lidiya Mykhaylechko
RGRoshna L. Gomez
Roshna L. Gomez
LWLaura M. Woods
Laura M. Woods
EPEvangelia K. Papachristou
Evangelia K. Papachristou
RRRevathy Ramachandran
Revathy Ramachandran
APAnna Philpott
Anna Philpott
Excel file listing the gene ontology terms and genes making up the neuronal gene signature.